Helen M. Palethorpe

28 Woodville Rd
Woodville South, SA 5011, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Novel GABAAR antagonists target networked gene hubs at the leading edge in high-grade gliomas.

Novel GABAAR antagonists target networked gene hubs at the leading edge in high-grade gliomas.

Journal: Neuro-oncology

Published: June 11, 2025

Personalising glioblastoma medicine: explant organoid applications, challenges and future perspectives.

Personalising glioblastoma medicine: explant organoid applications, challenges and future perspectives.

Journal: Acta neuropathologica communications

Published: September 17, 2024

Quaking isoforms cooperate to promote the mesenchymal phenotype.

Quaking isoforms cooperate to promote the mesenchymal phenotype.

Journal: Molecular biology of the cell

Published: November 29, 2023

Anti-Cancer Effects of an Optimised Combination of Ginsenoside Rg3 Epimers on Triple Negative Breast Cancer Models.

Anti-Cancer Effects of an Optimised Combination of Ginsenoside Rg3 Epimers on Triple Negative Breast Cancer Models.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: April 06, 2021

In Vitro Synergistic Inhibition of HT-29 Proliferation and 2H-11 and HUVEC Tubulogenesis by Bacopaside I and II Is Associated with Ca2+ Flux and Loss of Plasma Membrane Integrity.

In Vitro Synergistic Inhibition of HT-29 Proliferation and 2H-11 and HUVEC Tubulogenesis by Bacopaside I and II Is Associated with Ca2+ Flux and Loss of Plasma Membrane Integrity.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: March 22, 2021

Anti-Angiogenic Properties of Ginsenoside Rg3 Epimers: In Vitro Assessment of Single and Combination Treatments.

Anti-Angiogenic Properties of Ginsenoside Rg3 Epimers: In Vitro Assessment of Single and Combination Treatments.

Journal: Cancers

Published: March 11, 2021

Bacopasides I and II Act in Synergy to Inhibit the Growth, Migration and Invasion of Breast Cancer Cell Lines.

Bacopasides I and II Act in Synergy to Inhibit the Growth, Migration and Invasion of Breast Cancer Cell Lines.

Journal: Molecules (Basel, Switzerland)

Published: July 16, 2019

Stereoselective Anti-Cancer Activities of Ginsenoside Rg3 on Triple Negative Breast Cancer Cell Models.

Stereoselective Anti-Cancer Activities of Ginsenoside Rg3 on Triple Negative Breast Cancer Cell Models.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: May 15, 2019

Druggable Molecular Targets for the Treatment of Triple Negative Breast Cancer.

Druggable Molecular Targets for the Treatment of Triple Negative Breast Cancer.

Journal: Journal of breast cancer

Published: April 08, 2019

Bumetanide-Derived Aquaporin 1 Inhibitors, AqB013 and AqB050 Inhibit Tube Formation of Endothelial Cells through Induction of Apoptosis and Impaired Migration In Vitro.

Bumetanide-Derived Aquaporin 1 Inhibitors, AqB013 and AqB050 Inhibit Tube Formation of Endothelial Cells through Induction of Apoptosis and Impaired Migration In Vitro.

Journal: International journal of molecular sciences

Published: March 18, 2019

Reduced aquaporin-1 transcript expression in colorectal carcinoma is associated with promoter hypermethylation.

Reduced aquaporin-1 transcript expression in colorectal carcinoma is associated with promoter hypermethylation.

Journal: Epigenetics

Published: February 12, 2019

Ginsenoside Rg3: Potential Molecular Targets and Therapeutic Indication in Metastatic Breast Cancer.

Ginsenoside Rg3: Potential Molecular Targets and Therapeutic Indication in Metastatic Breast Cancer.

Journal: Medicines (Basel, Switzerland)

Published: December 20, 2018

Showing 1-12 of 20

Last Updated: 09/26/2026